During the past decade, Nashville Vision Associates conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 9 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 8 clinical trials were completed. i.e. 800% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nashville Vision Associates" #1 sponsor was "Allergan" with 3 trials, followed by "RVL Pharmaceuticals, Inc." with 2 trials sponsored, "Shire" with 2 trials sponsored, "Johnson & Johnson Vision Care, Inc." with 1 trials sponsored and "Santen Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Nashville Vision Associates" are "Blepharoptosis" (2 trials), "Presbyopia" (2 trials), "Adenoviral Conjunctivitis" (1 trials), "Bacterial Conjunctivitis" (1 trials) and "Dry Eye" (1 trials). Many other conditions were trialed in "Nashville Vision Associates" in a lesser frequency.

Most popular intervention types in "Nashville Vision Associates" are "Drug" (8 trials), "Other" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "PVP-I 0.6%" (2 trials), "Placebo" (2 trials), "RVL-1201" (2 trials), "SHP640" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nashville Vision Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Nashville Vision Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Nashville Vision Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nashville Vision Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".